STN
Not exactly a panic button
Wall Street Zen nudged Stantec from strong-buy to buy, which is more like taking the gas pedal from “mash it” to “just drive normally.” Not dramatic, but it does matter because rating changes can shift how traders frame the name.
The bigger headline is the mixed quarter
Stantec’s latest earnings were one of those classic “good news, bad news, please pick your poison” reports. EPS came in at $0.90, ahead of the $0.87 expected, but revenue landed at $1.19 billion versus a much higher $1.65 billion consensus.
Why investors should care
The stock still has a pretty supportive Wall Street backdrop: the analyst consensus remains Buy, with one Strong Buy, five Buy, and one Hold, plus a consensus target of $175. That said, the shares were trading at $91.26, so the market is clearly not buying the full fairy tale yet.
The takeaway
Stantec also stuck with FY2026 EPS guidance of $4.37 to $4.49, which gives investors a fresh anchor for expectations. Big picture: this isn’t a thesis-breaker, but it is a reminder that even in a friendly analyst setup, revenue misses can still cramp the party.